Cellerant Therapeutics, Inc. SBIR Phase II Award,
A SBIR Phase II contract was awarded to Cellerant Therapeutics for $1,496,276.0 USD from the U.S. Department of Health & Human Services.
Name
# Contributions
Last Contribution
Find more entities like Cellerant Therapeutics, Inc. SBIR Phase II Award,
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.